Raltegravir for use as a fascin1 inhibitor in cancer (Machine-translation by Google… Application ES-2919724-A1 Spain 27 Jul 2022
IMIPRAMINE FOR USE AS AN INHIBITOR OF FASCIN1 OVEREXPRESSION Application WO-2020065113-A1 World Intellectual Property Organisation (WIPO) 02 Apr 2020
IMIPRAMINE FOR USE AS INHIBITOR OF FASCIN1 OVEREXPRESSION Application EP-3628330-A1 European Patent Office 01 Apr 2020